Ann: ResApp Receives First Institutional Review Board Approval-RAP.AX, page-117

Check past threads there's precious few "what can go wrong" being discussed on RAP and for a while posts that do ask, were talked down as down-ramping.. there's no substitute for dyor. i've done mine and bought based on my working experience with some of the techniques behind the app.

No way however will i put my house on it. The sample rates of accuracy, specificity, etc.. didn't come with significance stats and that's probably (my guess) because the tests were under powered and inference can't be made for much larger groups of patients. The 64 billion dollar question is will the US trials deliver the same lofty results with a degree of confidence fit for a marketable product. i'm still dreaming big for ResApp tho' 64b market cap haha.

---------------------------------------------------------------------------------
what you follow me? but i thought i was following you from in front